By Steven L. Lewis, MD, Editor, and Walter Struhal, MD, Co-Editor
We’d like to welcome all readers to the April 2023 issue of World Neurology.

Walter Struhal, MD

Steven L. Lewis, MD
This issue includes heartfelt articles and tributes to recently departed neurologists, including the article by Dr. M. Akif Topcuoglu, president of the Turkish Neurological Society, about the devastating Turkiye-Syria earthquakes, with tributes to each of the five neurologists who passed away in the disaster.
This issue also includes obituaries and tributes to the late Prof. Johan Arli, a past-president of the World Federation of Neurology (WFN), written by WFN Past-President Raad Shakir and other colleagues of Prof. Arli from around the globe, including Nils Erik Gilhis, Ole-Björn Tysnes, Christian A. Vedeler, and Amadou Gallo Diop.
In this issue’s President’s Column, WFN President Dr. Wolfgang Grisold updates us on the many international activities in progress and being planned by the WFN, including the work being done with WHO and the Intersectoral Action Plan (IGAP), and the exciting plans for the World Congress of Neurology in Montreal this October, including the planning for the Annual Council of Delegates meeting.
Drs. Tissa Wijeratne and David Dodick (Co-Chairs of World Brain Day) as well as Drs. Lewis and Grisold provide a followup report on the plans for this year’s World Brain Day 2023, which will be dedicated to “Brain Health and Disability,” including collaborations between the WFN, our global regions, national neurologic societies, and the World Federation of Neurorehabilitation. Dr. Wijeratne is also congratulated on receiving the prestigious medal of the Order of Australia.
This issue’s History Column, by Dr. Peter J. Koehler, is devoted to an extensive book review on “The Idea of Epilepsy: A Medical and Social History of Epilepsy in the Modern Era” (1860-2020), by Dr. Simon D. Shorvon.
This issue also features several reports from recent national and international conferences. Kurt Niederkorn, Yong-Jae Kim, Hee-Jung Song, and Alex Razumovsky report on the joint conference of the Korean Society of Neurosonology and the WFN Neurosonology Research Group help in November 2022. Aida Kondybayeva reports on the Fifth International Educational Forum, the Neurology Update in Kazakhstan 2023 that was held in March 2023. Stefan Kiechl and Deidre De Silva report on the World Stroke Congress that occurred in October 2022 in Singapore. Finally, Carlos N. Ketzoian reports on the Second Latin American Course on Neuroepidemiology that was held in Punta del Este, Maldonado, Uruguay, this past March.
In closing, we want to thank all readers for their interest in and attention to World Neurology and the chance to report such important updates about neurology and neurologists from around the globe. We sincerely hope many of you are planning on attending the WCN in Montreal in October 2023 in person (for the first time since 2019) or virtually. •


Johan A. Aarli was an inspiring and highly respected neurologist with a worldwide influence. Sadly, he died March 24, 2023, at age of 86 years after a long illness. He made a huge professional impact locally, nationally, and globally. Prof. Aarli was a successful president of the World Federation of Neurology 2005-2009, and a general secretary of the European Association of Neurological Societies 2003-2005.
By Kurt Niederkorn, MD, Yong-Jae Kim, MD, PhD, Hee-Jung Song, MD, PhD, and Alex Razumovsky, PhD, FAHA, NVS
On Nov. 3-5, 2022, a joint conference of the Korean Society of Neurosonology (KSN) and NSG WFN considering clinical applications of carotid duplex, transcranial Doppler and transcranial color-coded duplex utilization in the wide arrays of different aspects of neurology, neurocritical care, and neurosurgery was conducted in Seoul, Korea. Invited speakers included prominent experts from Austria, Egypt, Germany, Japan, Korea, Portugal, Singapore, Switzerland, and the United States. Numerous speakers from Korean medical schools and universities were involved and presented high-quality clinical and research lectures.
A program full of lectures including teaching courses, hands-on sessions, poster sessions, international certification examination, and special interest events covering diverse topics, with networking and social activities, was presented. A special session was dedicated to sonography education where experts from Germany, Korea, and the United States exchanged opinions and presented country-specific approaches to neurosonology and ultrasound education in medical schools. However, the wide application of ultrasound, including neurosonology across many medical specialties, increased portability and decreased cost of ultrasound devices, and enhancement of learning both basic and clinical sciences with ultrasonography will continue to demand appropriate teaching and training on ultrasound in undergraduate medical education.
A special issue of the Korean Journal of Neurosonology and Neuroimaging (JNN) published all lectures and presentations (JNN, volume 14, supplement 2, November 2022).
Neurosonology has been developed based on ultrasound diagnosis in cerebrovascular diseases, like ischemic stroke and extracranial and intracranial stenosis, but is currently being applied and used clinically in various fields ranging from diagnosis and monitoring of cerebral vasospasm after subarachnoid hemorrhage and traumatic brain injury, and cerebral degenerative diseases, and to diagnose and follow up on peripheral nerve and muscle diseases.
Welcoming speeches to the participants were given by Prof. Saltanat Kamenova, president of KNANN; Prof. Zhanna Kalmataeva, dean of the faculty of medicine and health at al-Farabi KazNU; Aizhan Sadykova, president of the National Medical Association; and Symbat Abzalieva, deputy director of the Higher School of Medicine at al-Farabi KazNU. They noted the special significance of the forum for all practitioners who took part in this event.
The speakers of the Forum were Prof. Valery Feigin (New Zealand), Prof. Natan M. Bornstein (Israel), Prof. Adnan Siddiqui (U.S.), Prof. Afshin Divani (U.S.), Prof. Mesoud Ashina (Denmark), Prof. Tatyana Negrich (Ukraine), Prof. Aksel Siva (Turkey), as well as doctors from Kazakhstan: Saltanat Kamenova, Bagyzhan Syzdykova, Korlan Saduakasova, Tatiana Kaimak, Maksharip Martazanov, Aigul Akimniyazova, Gulnar Kabdrakhmanova, Karlygash Kuzhibaeva, and Aida Kondybaeva.
Within the framework of the forum, there was a master class titled, “Evidence-Based Neurology. How to Search for Information to Answer Specific Clinical Questions, Interpret and Critically Evaluate Scientific Evidence.” This training course was organized for young doctors and discussed the basic concepts and tools of evidence-based medicine, as well as their application in clinical and scientific practice. The course was conducted by doctors Maurizio Leone (Italy), Luca Vignatelli (Italy), Katina Aleksovska (Macedonia), and Teia Kobulashvili (Austria). •
On Feb. 6, 2023, two major earthquakes occurred, nine hours apart, with epicenters in Gaziantep and Kahramanmaraş in Turkiye. In this disaster, called the 2023 Turkiye-Syria earthquakes,” nearly 43,000 people died in Turkiye and 6,000 people in Syria. A total of approximately 150,000 people were injured, of which 120,000 were in Turkiye. It is estimated that at least 3 million people migrated from the affected zone to different cities after the earthquakes. Aftershocks still continue and pose a serious risk for rescue teams. Earthquakes affected 13.5 million Turkish people in an area of 1,000 square kilometers. This refers to about one-seventh of Turkiye’s population.




World Brain Day 2023 annually commemorates the foundation of the World Federation of Neurology (WFN) on July 22. The previous World Brain Day themes focused on specific neurological diseases such as Parkinson’s disease, migraine, epilepsy, multiple sclerosis, and many others. We are again partnering with all six regions of the WFN as well as the World Federation for NeuroRehabilitation (WFNR) to unite the world on the disability that results when brain health compromised.
The World Stroke Congress (WSC) is the flagship meeting of the World Stroke Organization (WSO). After the exclusively virtual events in 2021 and in 2020 (joint conference with the European Stroke Organization), the WSC 2022 in Singapore was the first international large-scale in-person meeting. With more than 4,400 attendees (approximately half in person and half online) this was the largest WSC ever. It served as an excellent opportunity to discuss latest clinical and research results with colleagues from all over the world. The participants were from 106 countries with highest attendance from colleagues from Australia, China, India, Indonesia, Malaysia, Philippines, Singapore, United Kingdom and the United States. The faculty of 204 invited speakers were well balanced across continents (Asia 34%, South and North America 24%, Europe 25%, Australia and Africa 18 %).
Pacific Stroke Organization, Association of Southeast Asian Nations Neurological Association, and WHO South-East Asia Regional Office. Stroke support organizations substantially contributed to the WSC 2022, integrated into the main program and also in parallel independent sessions. During the coffee breaks, there was dialogues on non-communicable diseases (NCD).
Patients with indications of endovascular stroke therapy according to DAWN or DEFUSE-3 criteria were also not considered. Other highlights were the meta-analysis of six trials comparing endovascular stroke therapy alone against bridging (combined with intravenous thrombolysis). In this meta-analysis including 2314 patients, endovascular stroke therapy could not prove to be non-inferior to bridging therapy and this is also valid for multiple subgroups. The first phase 3 trial on stem cells in stroke recovery (TREASURE) was negative, a lowering of systolic blood pressure under 120 in successful endovascular stroke therapy has negative impact on the patients’ outcome (ENCHANTED2), and treatment by tenecteplase was non-inferior to alteplase treatment (AcT Study).